Newsfeeds - Spark Newswire

2 minute read

Pfizer, OPKO Health Report FDA Issued Complete Response Letter For Biologics License Application For Their Somatrogon

Today, 4:09 PM

Pfizer Inc. (NYSE:PFE) and OPKO Health, Inc. (NASDAQ:OPK) announced today that the U.S. Food and Drug Administration (FDA) issued a Complete Response Letter (CRL) for the Biologics License Application (BLA) for

OPK

3 minute read

FDA
News

Japan’s Ministry Of Health, Labour And Welfare Approves Pfizer And OPKO’s NGENLA (Somatrogon), A New Long-Acting Treatment For Pediatric Growth Hormone Deficiency

By Benzinga Newsdesk

Today, 4:09 PM

https://www.globenewswire.com/news-release/2022/01/20/2370129/0/en/Japan-s-MHLW-Approves-Pfizer-and-OPKO-s-NGENLA-Somatrogon-a-New-Long-Acting-Treatment-for-Pediatric-Growth-Hormone-Deficiency.html Pfizer Japan Inc. and

OPK

2 minute read

12 Health Care Stocks Moving In Tuesday’s Intraday Session

By Benzinga Insights

Today, 4:09 PM

ARCT

3 minute read

Attention Biotech Investors: Mark Your Calendar For January PDUFA Dates

By Shanthi Rexaline

Today, 4:09 PM

Regulatory decisions by the U.S. Food and Drug Administration in December turned out to be mostly positive. Among the treatment options that were greenlighted in the month were two new molecular entities.

ALNY

1 minute read

Opko Health Posts Data From COVID-19 Trial With Its Kidney Disease Treatment

By Vandana Singh

Today, 4:09 PM

OPKO Health Inc (NASDAQ: OPK) has

OPK

2 minute read

Movers

12 Health Care Stocks Moving In Friday’s Intraday Session

By Benzinga Insights

Today, 4:09 PM

ABEO

2 minute read

28 Stocks Moving In Friday’s Mid-Day Session

By Lisa Levin

Today, 4:09 PM

Gainers Genfit SA (NASDAQ: GNFT) shares jumped 33.6% to $4.41 after the company, and Ipsen, announced an exclusive licensing agreement for elafibranor.

ABEO

1 minute read

News

OPKO Biologies Granted U.S. Patent #11,197,915 ‘Long-acting polypeptides and methods of producing and administering same’

By Charles Gross

Today, 4:09 PM

View Patent Here

OPK

2 minute read

OPKO Health Reports Received US FDA Approval For 4Kscore Test

By Benzinga Newsdesk

Today, 4:09 PM

OPKO Health, Inc. (NASDAQ:OPK) today announced that the U.S. Food and Drug Administration (FDA) has approved OPKO’s 4Kscore Test. This test is approved for use in men age 45 and older who have not had a

OPK

2 minute read

News

OPKO Health’s BioReference Laboratories Announces Readiness For COVID-19 Testing If Omicron COVID-19 Variant Emerges In U.S

By Benzinga Newsdesk

Today, 4:09 PM

BioReference Laboratories, Inc., an OPKO Health company (NASDAQ:OPK), announced COVID-19 testing preparedness for the Omicron Variant. BioReference's PCR diagnostic tests for SARS-CoV-2 COVID-19 are based on

OPK